# PHASE 6 — STAGE 2
## Track 1C — Controlled Chat UI — Usability / Presentation Polish
### Closeout / Reconciliation Record v1.0

**Status:** PASS / CLOSED
**Phase:** Phase 6 — Stage 2
**Track:** 1C
**Disposition:** CLOSED
**Next Workstream:** Track 2 Strategy Discussion

---

## 1. Objective

The objective of Track 1C was to upgrade the existing Phase 6 Controlled Chat UI from a functional prototype into a professional, readable, patient-oriented controlled research interface.

The approved UX direction was:

```text
Understand
    ↓
Ask
    ↓
Explore
````

with a patient-oriented question-guidance mechanism:

```text
Situation
    ↓
Topic
    ↓
Question Starter
    ↓
Populate Existing Input
    ↓
User Edit
    ↓
Explicit Send
    ↓
Existing /chat/query
```

Track 1C was limited to UI presentation and interaction.

---

## 2. Approved Scope

The approved Track 1C scope included:

* professional UI layout;
* typography and spacing;
* visual hierarchy;
* application identity;
* conversation presentation;
* patient-oriented situation navigation;
* topic presentation;
* question-starter presentation;
* input/send experience;
* loading state;
* error state;
* research/controlled-evaluation identity;
* disclaimer visibility;
* basic responsive browser layout.

The approved patient-oriented entry point was:

> Not sure what to ask? Start with your situation.

Track 1C was explicitly bounded as a presentation/interaction layer and did not implement the longer-term backend navigation architecture.

---

## 3. Implementation

The Track 1C implementation modified:

```text
08_Development/implementation/src/safe_medical_ai/api/chat_ui.py
08_Development/implementation/tests/test_chat_ui.py
```

`main.py` was not modified by Track 1C.

The UI was redesigned with:

* application header and identity;
* Research / Controlled Evaluation badge;
* structured navigation sidebar;
* Situation → Topic → Question Starter interaction;
* professional cards/chips and visual hierarchy;
* improved chat presentation;
* visible research disclaimer;
* responsive layout behavior.

The legacy gastric-cancer-nomogram source was used only as a visual/UX reference.

No legacy clinical/model/calculation logic or legacy application architecture was imported.

---

## 4. Preserved Boundaries

The following were explicitly preserved and were not changed by Track 1C:

```text
/chat contract
/chat/query contract
CER
CER orchestration
retrieval
PP resolution
evidence capture
239-case mechanism
239-PP execution
backend navigation context
RAG integration
LLM-generated question suggestions
patient-specific reasoning
patient-state persistence
clinical decision logic
```

The existing Track 1B execution path remains:

```text
Browser
   ↓
/chat
   ↓
/chat/query
   ↓
existing governed CER path
   ↓
PP-0002 + CKO
   ↓
deterministic CER response
```

Track 1C did not generalize PP-0002 and did not implement Track 2.

---

## 5. Automated Verification

Track 1C focused tests:

```text
21 passed
```

This consisted of:

```text
16 existing Track 1A/1B tests
+
5 Track 1C-specific tests
=
21 passed
```

The existing 16 tests were preserved without modification.

Full implementation regression:

```text
313 passed
```

`git diff --check`:

```text
PASS / CLEAN
```

The implementation was additionally checked for scope violations and unintended legacy technology leakage.

No React/Tailwind/npm/lucide-react implementation was introduced.

---

## 6. Human Browser Run

Track 1C Human Run was performed on the real browser-facing application.

All nine approved checks passed:

| # | Human Run Check                       | Result |
| - | ------------------------------------- | ------ |
| 1 | Initial professional UI renders       | PASS   |
| 2 | Situation selection                   | PASS   |
| 3 | Topic selection                       | PASS   |
| 4 | Question-starter population           | PASS   |
| 5 | Question starter does not auto-submit | PASS   |
| 6 | Edit + explicit Send                  | PASS   |
| 7 | Real CER response / `COMPLETED`       | PASS   |
| 8 | Responsive layout                     | PASS   |
| 9 | Disclaimer visibility                 | PASS   |

The interaction demonstrated:

```text
Situation
    ↓
Topic
    ↓
Question Starter
    ↓
Input populated
    ↓
No automatic submission
    ↓
User edits if desired
    ↓
User presses Send
    ↓
/chat/query
    ↓
Existing Track 1B CER path
    ↓
COMPLETED response
```

---

## 7. Evidence / Reconciliation

The combined automated and human evidence is sufficient to demonstrate the approved Track 1C objective.

The evidence demonstrates that:

1. the UI presentation was successfully upgraded;
2. the patient-oriented two-tier question-guidance interaction works;
3. question starters do not bypass the user's explicit Send action;
4. the existing Track 1B execution path remains functional;
5. the existing test suite remains passing;
6. the browser-facing interface remains usable after the redesign;
7. the research/non-clinical-validation boundary remains visible.

No evidence identified a Track 1C defect that blocks the approved objective.

The current controlled-evaluation coverage remains:

```text
1 / 239
```

Track 1C does not claim 239-PP controlled evaluation.

---

## 8. Deviations / Issues

No unresolved Track 1C implementation issue remains.

No new governance requirement was introduced.

No new clinical validation requirement was introduced.

No remediation/refinement loop is opened.

The following remain intentionally outside Track 1C:

```text
239-PP controlled evaluation
batch evaluation architecture
PP generalization
backend navigation engine
dynamic retrieval
RAG
LLM navigation/reasoning
patient-state persistence
clinical validation
clinical deployment
```

These are not Track 1C defects.

---

## 9. Final Decision

# PASS / CLOSED

Track 1C has satisfied its approved bounded objective.

The Track 1C implementation is accepted as complete.

Track 1C SHALL NOT be reopened merely for additional visual refinement unless a future, explicitly approved objective requires such work.

No additional Track 1C QA/remediation cycle is required.

---

## 10. Handoff / Next State

Phase 6 Stage 2 Track 1 is now complete:

```text
Track 1A
PASS / CLOSED
      ↓
Track 1B
PASS / CLOSED
      ↓
Track 1C
PASS / CLOSED
      ↓
TRACK 1 COMPLETE
```

The next workstream is:

```text
TRACK 2
```

Track 2 will address the approved Phase 6 objective of expanding the controlled execution surface beyond the current PP-0002 boundary toward the full:

```text
239 PP
```

controlled-evaluation coverage.

Track 2 must preserve the established project principle:

> Do not invent a batch architecture or remediation/refinement loop unless the existing implementation capability is first inspected and shown to be insufficient for the approved 239-PP objective.

The next step is therefore **Track 2 strategy discussion**, not immediate implementation.

Phase 7 remains unchanged.

---

## Closeout Summary

```text
PHASE 6 — STAGE 2

Track 1A ................. PASS / CLOSED
Track 1B ................. PASS / CLOSED
Track 1C ................. PASS / CLOSED

Track 1 Status ........... COMPLETE

Current PP Coverage ...... 1 / 239

Next ..................... Track 2 Strategy Discussion

Phase 7 .................. UNCHANGED
```

**Record Status:** FINAL — CLOSED

````
```
